Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -185.05x is 39% below its 4-year average of -133.02x, near the high end of its 4-year range (-1454.05x–3.72x).
113.68% below its 12-month average of -86.60x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3.69x.
INTEREST COVERAGE RATIO
-185.05x
INTEREST COVERAGE RATIO AVG TTM
-86.60x
INTEREST COVERAGE RATIO AVG 3Y
-93.67x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-113.68%
CURRENT VS 3Y AVG
-97.55%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.85x
median of 397 covered companies
CURRENT VS SECTOR MEDIAN
-3715.46%
vs the sector median at left
Mangoceuticals, Inc.
Market Cap
$7.01M
Interest Coverage Ratio
-185.05x
TTM Avg
-86.60x
3Y Avg
-93.67x
5Y Avg
N/A
Market Cap
$7.07M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.23M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.33M
Interest Coverage Ratio
-924.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.92M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.93M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mangoceuticals, Inc. (MGRX) | $7.01M | -185.05x | -86.60x | -93.67x | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.22M | -11.95x | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.23M | -496.55x | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.33M | -924.78x | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.33M | N/A | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.92M | N/A | N/A | N/A | N/A |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.93M | N/A | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.70M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.67M | -82777.81x | 11.97x | 11.97x | 11.97x |
Interest Coverage
-185.1x
Debt/Equity
0.03
Current Ratio
0.18
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3.69x |
| 2026-03-31 | -11.29x |
| 2025-12-31 | -75.80x |
| 2025-09-30 | -99.45x |
| 2025-06-30 | -242.79x |
| 2024-12-31 | 3.72x |
| 2024-09-30 | -7.28x |
| 2024-06-30 | -9.74x |
| 2023-12-31 | -396.73x |
| 2023-03-31 | -1454.05x |
| 2022-12-31 | -373.25x |
| 2022-09-30 | -320.98x |
| 2022-06-30 | -207.14x |
| 2022-03-31 | -21.05x |
| 2021-12-31 | -96.80x |
